# A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

> **NCT03057509** · PHASE1 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Small Bowel Carcinoid Tumor

## Interventions

- **DRUG:** Ga-68-DOTA-TOC
- **DEVICE:** Siemens PET/MR scanner
- **OTHER:** Standard Siemens Software
- **DRUG:** LAR Octreotide

## Key facts

- **NCT ID:** NCT03057509
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-11
- **Primary completion:** 2019-10-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057509, "A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03057509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*